Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Cell Dyscrasias”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableLooking for participantsNCT01408225
What this trial is testing

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

Who this might be right for
Plasma Cell DyscrasiasMonoclonal Gammopathy of Undetermined SignificanceAL Amyloidosis+1 more
Ohio State University Comprehensive Cancer Center 5,000
Testing effectiveness (Phase 2)Study completedNCT02556931
What this trial is testing

Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

Who this might be right for
Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaSmall Lymphocytic Lymphoma+11 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 117
Testing effectiveness (Phase 2)Study completedNCT00048412
What this trial is testing

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Who this might be right for
Myelodysplastic DisordersLeukemiaMultiple Myeloma+2 more
Baylor College of Medicine 40
Not applicableUnknownNCT03405571
What this trial is testing

Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.

Who this might be right for
Multiple MyelomaVenous Thromboembolism
University of Athens 800
Testing effectiveness (Phase 2)Study completedNCT01816620
What this trial is testing

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

Who this might be right for
POEMS Syndrome
Peking Union Medical College Hospital 41
Large-scale testing (Phase 3)Study completedNCT03480360
What this trial is testing

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more
Dartmouth-Hitchcock Medical Center 21
Not applicableStudy completedNCT02741999
What this trial is testing

A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early

Who this might be right for
Plasma Cell DyscrasiaMonoclonal Gammopathy
Tufts Medical Center 20
Not applicableLooking for participantsNCT03616483
What this trial is testing

The Indiana Myeloma Registry

Who this might be right for
Plasma Cell Dyscrasias
Indiana University 2,500
Not applicableStudy completedNCT01186224
What this trial is testing

Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC)

Who this might be right for
Multiple MyelomaPlasma Cell DyscrasiaLymphoma+1 more
University of Liverpool 60
Testing effectiveness (Phase 2)Looking for participantsNCT04879043
What this trial is testing

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Disorder
Heidelberg Pharma AG 78
Large-scale testing (Phase 3)WithdrawnNCT02155634
What this trial is testing

Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma

Who this might be right for
Multiple MyelomaNeoplasmsPlasma Cells+4 more
Celgene
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07751471
What this trial is testing

BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)

Who this might be right for
AL Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Ended earlyNCT00942422
What this trial is testing

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
Barbara Ann Karmanos Cancer Institute 8
Post-approval studies (Phase 4)Study completedNCT04080531
What this trial is testing

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Who this might be right for
Plasma Cell Neoplasm
Emory University 165
Testing effectiveness (Phase 2)Looking for participantsNCT07075510
What this trial is testing

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Who this might be right for
Plasma Cell Disorder
University of Maryland, Baltimore 30
Very early researchNot Yet RecruitingNCT07365059
What this trial is testing

Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders

Who this might be right for
Plasma Cell Dyscrasias
Qi deng 18
Testing effectiveness (Phase 2)Study completedNCT02041325
What this trial is testing

Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias

Who this might be right for
Plasma Cell Disorder
Boston VA Research Institute, Inc. 38
Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Not applicableNot Yet RecruitingNCT06286215
What this trial is testing

Registry of Patients With Plasma Cell Disorders

Who this might be right for
Plasma Cell Disorders
Siriraj Hospital 750
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Next Page